Description
March 18, 2025 | 2:00-3:00 PM
Description:
During this webinar, we will discuss various buprenorphine formulations and their use during pregnancy. We will also describe strategies for successfully implementing buprenorphine during pregnancy including low and high dose initiation as well as use of the extended-release product. Finally, we will review other key components of caring for pregnant women with opioid use disorder such as breastfeeding and pain management recommendations, substance exposed infant notification, and concurrent hepatitis C.
Learning Objectives:
- Discuss buprenorphine formulations and related use during pregnancy
- Describe strategies for initiating buprenorphine during pregnancy
- Review implications of opioid use disorder in pregnancy (e.g., SEI notification, breastfeeding implications, concurrent Hepatitis C)
Presenters:
Alane O’Connor, DNP
Alane O’Connor, DNP is the director of perinatal addiction medicine at Maine Medical Center and is the medical advisor of the Maine Maternal Opioid Misuse (MaineMOM) Initiative, a 5-year, $5 million federal grant to expand access to substance use treatment for pregnant and postpartum individuals in Maine. She also co-chairs Maine’s Opioid Response Clinical Advisory Committee, which advises the Governor’s opioid response director on clinical and public policy issues. Dr. O’Connor has more than 15 years of experience in addiction medicine in a variety of settings including the design and implementation of an extended-release buprenorphine pilot at Somerset County Jail, rapid access to substance use treatment in emergency departments through Maine Medical Association’s Project RISE, as well extensive experience caring for pregnant patients with substance use disorder in both the inpatient and outpatient settings. She lectures regionally and nationally and has trained more than 100 family medicine and obstetric resident physicians. She is a core faculty member of Maine’s only addiction medicine fellowship program. Finally, she has published numerous peer reviewed articles on maternal and infant outcomes of substance exposed pregnancies including the related child welfare implications as well as the care of incarcerated pregnant patients.
Audience:
Prescribing Clinicians and their teams
Continuing Medical Education:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.
Contact Hours
1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.
